InvestX
Pre-IPO unicorn investing for accredited investors
Pros & Cons
Pros
- Curated unicorn access
- Secondary pricing
Cons
- Accredited only
- Illiquid
- High minimums
The Brief
MoneyMade Verdict
InvestX gives accredited investors structured access to pre-IPO equity in late-stage private companies — but high minimums, limited deal flow, and a Canadian regulatory lens make it a niche fit rather than a primary startup investing platform for most U.S. investors.
InvestX is a Canadian-founded platform, launched in 2014, that gives accredited investors access to late-stage private company shares through pooled vehicles managed by its team. The platform's original thesis was simple: unicorn-adjacent startups are increasingly staying private longer, and by the time they IPO, much of the value creation has already been captured by institutional investors. InvestX was built to shorten that gap by aggregating retail accredited capital into institutional-sized allocations at later, lower-risk funding rounds — typically Series C and beyond. The company is headquartered in Vancouver with U.S. operations in New York, and is regulated as a broker-dealer under both Canadian (IIROC) and U.S. (FINRA) frameworks.
The platform's core offering is access to InvestX Capital Fund vehicles, which pool investor capital to acquire secondary market shares or primary allocations in companies like SpaceX, Stripe, Databricks, and Klarna. Minimums typically start at $10,000 but scale higher depending on the specific deal and fund structure. Unlike direct-access platforms such as Forge or EquityZen — where investors buy specific share lots on a transaction-by-transaction basis — InvestX's fund model means you're investing in a portfolio manager's selected basket, which provides built-in diversification but removes direct control over which companies you own.
Head-to-Head
| Platform | Min | Target Return | Annual Fee | Liquidity | Accredited |
|---|---|---|---|---|---|
| — | Illiquid equity | Transaction fee | 3–7 years | Yes | |
| $25K | 6–8% | 1.5% annual management | 5–15 years | Yes | |
| $10K | VC-style returns | 2% management + 20% carry | 5–10 years | Yes | |
| $100 | 8–12% | 1% annual fee | 5–25 years | No | |
| $100 | 4–8% | Varies by offering | 5–20 years | No |
Also in Private Companies
AgFunder
commodities
Min N/ALearn more →AngelList
private companies
Min $1KLearn more →Arta Finance
stocks
Min N/ALearn more →Bioverge
private companies
Min N/ALearn more →Carta
private companies
Min N/ALearn more →Commonwealth
stocks
Min N/ALearn more →